-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
3 Managed Care Companies That Could Score From Obamacare, if …
... the High Court upholds the health care reform law in toto. The mandate for all Americans to have coverage would bring in lots of young, healthy new members to these managed care companies.
A Steady Boat in Rough Biotech Waters
PDL BioPharma's (PDLI) isn't your everyday biopharmaceutical company -- it has a more predictable revenue stream, and even a substantial dividend payout.
Biotech’s Regeneron Is a New Game Changer Buy
Biotech's Regeneron is a strong buy based on its existing Eylea drug for macular degeneration, but the company also has a solid pipeline of products.
My Favorite Sector for Summer: Biotech
Stocks can suck in the summertime, but not every sector is doomed: Here's why biotech could be the season's sweetheart, and which stocks look hot.
7 Biotech Stocks to Add to Your Portfolio
The biotech business is working overtime to find the next breakthrough drugs and treatments for a population that gets older every day.
4 Stocks Buffett May Be Buying in Europe
A look at the Oracle's buying behavior in the past clues you in to where his cash is likely being funneled now.
3 Hospital Stocks for a Healthy Portfolio
No matter if Obamacare thrives or gets thrashed, these name should prosper because they're making moves now that will pay off down the road either way.
Tough Market? Not for Defensive Stocks
The market has been hit hard since the start of April, but not all sectors have lost ground. Find out what has been working through this difficult tape.
Gilead Sciences’ HIV Drugs Clear a Hurdle
Full FDA approval should come next -- but if not, watch out, because Gilead is very heavily dependent on its HIV drug lineup, and patents will be expiring.
Obesity: The Next Investment Driver
The global market for weight-control products of all types is forecast to hit $53 billion in just five years, and several companies are primed to profit.
6 Flatlining Healthcare Stocks to Sell
Healthcare stocks are under pressure as patents expire and margins are pressed. Consider selling these 6 laggards from the portfolio.
Health Insurers Weathering Sickly Q1 Results
A large swath of managed care companies had lousy Q1 earnings, but few have fallen to bargain prices. Are there any values to be found in the sector?
4 Sick Healthcare Stocks to Sell
Healthcare stocks are subject to patent problems and pricing pressures on contracts. Not everyone is doing well, and these 4 stocks are a sell
Pfizer is Still a Pharmaceutical-Giant Buy
Despite a slowdown in sales as Lipitor becomes a generic drug, pharma giant Pfizer is still a very good buy, and a great play for your portfolio.
Pfizer: Profits Drop, Beat Forecasts
Pfizer's first-quarter earnings and revenue declined, led by dropping sales for Lipitor, but beat analysts’ forecasts, even as it lowered its outlook.
Watson Pharmaceuticals Is No Ordinary Generic
Watson Pharmaceuticals is an outstanding company that grows earnings and revenues every year in the tough generic pharma space. Consider this a top buy.
AstraZeneca CEO Resigns, Shares Drop
CEO David Brennan departs after the company reported lower earnings and sales for the last quarter and a diminished outlook for the year.
7 Health Care Stocks to Get Your Portfolio Well
The health care industry is alive and kicking, and these 7 stocks are doing particularly well. Add them to your portfolio today.
Why Biotech Investing Is So Hard
It spikes wildly when gaining, plunges quickly when falling -- and normal strategies don't apply.
